Search Results

Biotech Beach

ImmunoScape Leadership to Present at Upcoming March 2024 Industry Conferences

ImmunoScape, a biotechnology company focused on next-generation T Cell receptor -based immunotherapies, announced that members of its executive team will present at two upcoming conferences, BioCentury-BayHelix East-West Summit 2024 and The State of Precision Medicine 2024.

March 1, 2024

·

2 min read

Biotech Beach

ImmunoScape Announces Three Presentations Highlighting TCR Pipeline and Discovery Platform at the American Association for Cancer Research (AACR) Annual Meeting 2024

ImmunoScape today announced that three abstracts have been accepted for poster presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting taking place April 5-10, 2024 in San Diego, California.

March 20, 2024

·

2 min read

Business

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

ImmunoScape and MiNK Therapeutics, Inc today announced a collaboration agreement to discover and develop next-generation TCR therapies against novel targets in solid tumors.

December 20, 2023

·

4 min read

Business

ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics

ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics.

December 21, 2023

·

3 min read

Business

ImmunoScape Appoints Systems Immunology and Computational Biology Expert Dr. John Tsang to its Scientific Advisory Board

ImmunoScape, a biotechnology company focused on next-generation immunotherapies, announced the appointment of John Tsang, Ph.D. to its Scientific Advisory Board.

December 12, 2023

·

5 min read

Biotech Beach

ImmunoScape Uses Machine Learning to Accurately Predict Antigen Specificity Based on T-Cell Phenotypes in New Peer-Reviewed Research

ImmunoScape, a biotechnology company focused on next-generation immunotherapies, published new peer-reviewed research that demonstrates the use of machine learning to predict the virus specificity of human T-cells.

October 19, 2023

·

4 min read

Biotech Beach

ImmunoScape To Present at the 7th Annual CAR-TCR Summit

ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics, today announced that Dan MacLeod, Ph.D., the company’s vice president of discovery, will present at the 7th Annual CAR-TCR Summit taking place September 19-22, 2022 in Boston.

September 15, 2022

·

2 min read

Biotech Beach

ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors

ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics today announced that it has raised $14M in new financing.

September 20, 2022

·

4 min read

Business

ImmunoScape Inks Licensing Deal with Pure MHC to Advance Development of Novel TCR-Based Therapies

ImmunoScape, today announced that it has signed a licensing deal with Pure MHC, LLC, a target discovery and development company, to pursue TCR-T therapeutics against Pure MHC-identified antigens in lung cancer, colorectal cancer, and other cancer indications.

February 16, 2022

·

4 min read

Business

ImmunoScape Expands its Executive and Scientific Teams to Extend Use of its Deep Immunomics Platform into Drug Discovery

ImmunoScape today announced it has made three strategic additions to its global team to expand the use of its innovative technology platform for drug discovery.

June 29, 2021

·

5 min read